These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 11377837

  • 1. Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment.
    Marksteiner J, Weiss U, Weis C, Laslop A, Fischer-Colbrie R, Humpel C, Feldon J, Fleischhacker WW.
    Neuroscience; 2001; 104(2):325-33. PubMed ID: 11377837
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of phencyclidine application on secretogranin II expression in organotypic slices of rat prefrontal cortex.
    Hinterhoelzl JK, Salimi K, Humpel C, Singewald N, Adlassnig C, Fischer-Colbrie R, Fleischhacker WW, Marksteiner J.
    J Neurochem; 2003 Oct; 87(1):13-21. PubMed ID: 12969248
    [Abstract] [Full Text] [Related]

  • 3. Synaptic proteins in Alzheimer's disease.
    Marksteiner J, Kaufmann WA, Gurka P, Humpel C.
    J Mol Neurosci; 2002 Oct; 18(1-2):53-63. PubMed ID: 11931350
    [Abstract] [Full Text] [Related]

  • 4. Proteolytic processing, axonal transport and differential distribution of chromogranins A and B, and secretogranin II (secretoneurin) in rat sciatic nerve and spinal cord.
    Li JY, Leitner B, Lovisetti-Scamihorn P, Winkler H, Dahlström A.
    Eur J Neurosci; 1999 Feb; 11(2):528-44. PubMed ID: 10051753
    [Abstract] [Full Text] [Related]

  • 5. Distribution of chromogranins A and B and secretogranin II (secretoneurin) in rat pelvic neurons and vas deferens.
    Li JY, Leitner B, Winkler H, Dahlström A.
    Neuroscience; 1998 May; 84(1):281-94. PubMed ID: 9522381
    [Abstract] [Full Text] [Related]

  • 6. Differential regulation of chromogranin A, chromogranin B and secretoneurin protein expression after transient forebrain ischemia in the gerbil.
    Martí E, Ferrer I, Blasi J.
    Acta Neuropathol; 2001 Feb; 101(2):159-66. PubMed ID: 11271371
    [Abstract] [Full Text] [Related]

  • 7. Molecular characterization of immunoreactivities of peptides derived from chromogranin A (GE-25) and from secretogranin II (secretoneurin) in human and bovine cerebrospinal fluid.
    Kirchmair R, Benzer A, Troger J, Miller C, Marksteiner J, Saria A, Gasser RW, Hogue-Angeletti R, Fischer-Colbrie R, Winkler H.
    Neuroscience; 1994 Dec; 63(4):1179-87. PubMed ID: 7535395
    [Abstract] [Full Text] [Related]

  • 8. Regulation of chromogranin biosynthesis by neurotrophic growth factors in neuroblastoma cells.
    Weiss C, Winkler H, Laslop A.
    Neurochem Int; 2001 Jan; 38(1):43-52. PubMed ID: 10913687
    [Abstract] [Full Text] [Related]

  • 9. Regulation of the biosynthesis and processing of chromogranins in organotypic slices: influence of depolarization, forskolin and differentiating factors.
    Bauer R, Hoflehner J, Doblinger A, Kapeller I, Laslop A.
    Eur J Neurosci; 2000 Aug; 12(8):2746-56. PubMed ID: 10971617
    [Abstract] [Full Text] [Related]

  • 10. Temporal lobe epilepsy of the rat: differential expression of mRNAs of chromogranin B, secretogranin II, synaptin/synaptophysin and p65 in subfield of the hippocampus.
    Mahata SK, Marksteiner J, Sperk G, Mahata M, Gruber B, Fischer-Colbrie R, Winkler H.
    Brain Res Mol Brain Res; 1992 Nov; 16(1-2):1-12. PubMed ID: 1334187
    [Abstract] [Full Text] [Related]

  • 11. Localization and axotomy-induced regulation of the peptide secretoneurin in the rat superior cervical ganglion.
    Klimaschewski L, Kroesen S, Eder U, Leitner B, Fischer-Colbrie R.
    Eur J Neurosci; 1996 Sep; 8(9):1953-64. PubMed ID: 8921286
    [Abstract] [Full Text] [Related]

  • 12. Chromogranin mRNA levels in the brain as a marker for acute and chronic changes in neuronal activity: effect of treatments including seizures, osmotic stimulation and axotomy in the rat.
    Shen PJ, Gundlach AL.
    Eur J Neurosci; 1996 May; 8(5):988-1000. PubMed ID: 8743747
    [Abstract] [Full Text] [Related]

  • 13. Up-regulation of secretoneurin immunoreactivity and secretogranin II mRNA in rat striatum following 6-hydroxydopamine lesioning and chronic L-DOPA treatment.
    Medhurst AD, Zeng BY, Charles KJ, Gray J, Reavill C, Hunter AJ, Shale JA, Jenner P.
    Neuroscience; 2001 May; 105(2):353-64. PubMed ID: 11672603
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseases.
    Eder U, Leitner B, Kirchmair R, Pohl P, Jobst KA, Smith AD, Málly J, Benzer A, Riederer P, Reichmann H, Saria A, Winkler H.
    J Neural Transm (Vienna); 1998 May; 105(1):39-51. PubMed ID: 9588759
    [Abstract] [Full Text] [Related]

  • 19. CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin).
    Miller C, Kirchmair R, Troger J, Saria A, Fleischhacker WW, Fischer-Colbrie R, Benzer A, Winkler H.
    Biol Psychiatry; 1996 Jun 01; 39(11):911-8. PubMed ID: 9162202
    [Abstract] [Full Text] [Related]

  • 20. Secretoneurin--a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C).
    Kirchmair R, Hogue-Angeletti R, Gutierrez J, Fischer-Colbrie R, Winkler H.
    Neuroscience; 1993 Mar 01; 53(2):359-65. PubMed ID: 8492910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.